These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 23457800

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16 E7 in a mouse model.
    Jia Y, Yin Y, Duan F, Fu H, Hu M, Gao Y, Pan Z, Jiao X.
    Int J Mol Med; 2012 Dec; 30(6):1335-42. PubMed ID: 23027427
    [Abstract] [Full Text] [Related]

  • 3. The contribution of NT-gp96 as an adjuvant for increasing HPV16 E7-specific immunity in C57BL /6 mouse model.
    Mohit E, Bolhassani A, Zahedifard F, Taslimi Y, Rafati S.
    Scand J Immunol; 2012 Jan; 75(1):27-37. PubMed ID: 21916914
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Strong immune responses induced by a DNA vaccine containing HPV16 truncated E7 C-terminal linked to HSP70 gene.
    Meshkat Z, Soleimanjahi H, Mirshahabi H, Meshkat M, Kheirandish M, Hassan ZM.
    Iran J Immunol; 2011 Jun; 8(2):65-75. PubMed ID: 21705833
    [Abstract] [Full Text] [Related]

  • 7. A novel self-assembled nanoparticle vaccine with HIV-1 Tat₄₉₋₅₇/HPV16 E7₄₉₋₅₇ fusion peptide and GM-CSF DNA elicits potent and prolonged CD8⁺ T cell-dependent anti-tumor immunity in mice.
    Tang J, Yin R, Tian Y, Huang Z, Shi J, Fu X, Wang L, Wu Y, Hao F, Ni B.
    Vaccine; 2012 Feb 01; 30(6):1071-82. PubMed ID: 22178528
    [Abstract] [Full Text] [Related]

  • 8. Fungal mannosylation enhances human papillomavirus 16 E7 therapeutic immunity against TC-1 tumors.
    Wang Z, Wei C, Zhang Y, Wang W, Zhou Z, Xiao G.
    Oncol Rep; 2018 Jan 01; 39(1):425-432. PubMed ID: 29115562
    [Abstract] [Full Text] [Related]

  • 9. Regression of HPV-positive tumors treated with a new Listeria monocytogenes vaccine.
    Sewell DA, Douven D, Pan ZK, Rodriguez A, Paterson Y.
    Arch Otolaryngol Head Neck Surg; 2004 Jan 01; 130(1):92-7. PubMed ID: 14732776
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model.
    Salehi M, Taheri T, Mohit E, Zahedifard F, Seyed N, Taslimi Y, Sattari M, Bolhassani A, Rafati S.
    Immunotherapy; 2012 Nov 01; 4(11):1107-20. PubMed ID: 23194361
    [Abstract] [Full Text] [Related]

  • 12. Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice model.
    Daemi A, Bolhassani A, Rafati S, Zahedifard F, Hosseinzadeh S, Doustdari F.
    Immunol Lett; 2012 Dec 17; 148(2):117-25. PubMed ID: 23085605
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Enhanced anti-tumor effects of HPV16E7(49-57)-based vaccine by combined immunization with poly(I:C) and oxygen-regulated protein 150.
    Chen S, Ou R, Tang J, Deng X, Wu Y, van Velkinburgh JC, Ni B, Xu Y.
    Cancer Epidemiol; 2013 Apr 17; 37(2):172-8. PubMed ID: 23127963
    [Abstract] [Full Text] [Related]

  • 15. Oral immunization with recombinant Lactococcus lactis NZ9000 expressing human papillomavirus type 16 E7 antigen and evaluation of its immune effects in female C57BL/6 mice.
    Mohseni AH, Razavilar V, Keyvani H, Razavi MR, Khavari-Nejad RA.
    J Med Virol; 2019 Feb 17; 91(2):296-307. PubMed ID: 30192395
    [Abstract] [Full Text] [Related]

  • 16. Both E7 and CpG-oligodeoxynucleotide are required for protective immunity against challenge with human papillomavirus 16 (E6/E7) immortalized tumor cells: involvement of CD4+ and CD8+ T cells in protection.
    Kim TY, Myoung HJ, Kim JH, Moon IS, Kim TG, Ahn WS, Sin JI.
    Cancer Res; 2002 Dec 15; 62(24):7234-40. PubMed ID: 12499264
    [Abstract] [Full Text] [Related]

  • 17. [Linkage of modified human papillomavirus type 16 E7 to CD40 ligand enhances specific CD8+ T-lymphocyte induction and anti-tumour activity of DNA vaccine].
    Wang QY, Xu YF, Fan DS, Peng QL, Zhang T, Xu XM.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct 15; 29(5):584-91. PubMed ID: 18051710
    [Abstract] [Full Text] [Related]

  • 18. Immunization of protein HPV16 E7 in fusion with mouse HSP70 inhibits the growth of TC-1 cells in tumor bearing mice.
    Li YL, Liu J, Liu JN, Zhang J.
    Vaccine; 2011 Aug 11; 29(35):5959-62. PubMed ID: 21722685
    [Abstract] [Full Text] [Related]

  • 19. Immunization of mice by the co-administration of codon-optimized HPV16 E7 and lL12 genes against HPV16-associated cervical cancer.
    Ajorloo M, Alamdary A, Soleimanjahi H, El Boulani A, Khanizadeh S, Nikoo HR.
    Microb Pathog; 2019 Jul 11; 132():20-25. PubMed ID: 31004722
    [Abstract] [Full Text] [Related]

  • 20. Oral vaccination with recombinant Listeria monocytogenes expressing human papillomavirus type 16 E7 can cause tumor growth in mice to regress.
    Lin CW, Lee JY, Tsao YP, Shen CP, Lai HC, Chen SL.
    Int J Cancer; 2002 Dec 20; 102(6):629-37. PubMed ID: 12448006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.